Back to Authors

Kellow, J. E.

Mayo Clinic

Mayo Clinic

Citations 1

Altered sensitivity of the gallbladder to cholecystokinin octapeptide in irritable bowel syndrome
Kellow, J. E., Phillips, S. F., Zinsmeister, Alan R., Charboneau, J. William, Miller, Laurence J.

American Journal of Physiology-Gastrointestinal and Liver Physiology | December 24, 2017 | Volume: 253 | Issue: 5 | Pages: G650-G655

10.1152/ajpgi.1987.253.5.g650 Get It

We compared responses of the gallbladder to graded intravenous infusions of cholecystokinin octapeptide (CCK-OP) in normal controls (n = 8) and patients with irritable bowel syndrome (IBS) with predominant constipation (n = 8) or diarrhea (n = 8). The doses of CCK-OP ranged from subphysiological (negligible contraction of the gallbladder) to supraphysiological (90% contraction of gallbladder and abdominal side effects) amounts. All gallbladders contracted progressively in response to CCK-OP, and a Weibull model (power exponential function) described precisely the gallbladder's response to CCK-OP. Patients with IBS responded differently from normal patients; those with constipation contracted their gallbladders more and those with diarrhea contracted less in response to the peptide. Gallbladders were also stimulated with a high-fat, liquid meal; all patients' gallbladders contracted, but clear differences between groups could not be demonstrated postprandially. The results suggest that the smooth muscle of the gallbladder in IBS has an abnormal sensitivity to CCK-OP, and the results support the concept that IBS can be a generalized abnormality of the smooth muscle of the digestive tract.